We are live on !
Find out more
AO
Advisor OS Portfolio holdings
AUM
$1.5B
Turnover
15.56%
1-Year Est. Return
21.75%
This Fund
S&P 500
This Quarter Est. Return
+12.35%
1 Year Est. Return
+21.75%
3 Year Est. Return
+61.18%
5 Year Est. Return
+74.66%
10 Year Est. Return
–
AUM
$1.5B
AUM Growth
+$117M
(+8.5%)
Cap. Flow
-$8.03M
Cap. Flow % of AUM
Cap. Flow %
-0.54%
Top 10 Holdings %
Top 10 Hldgs %
36.97%
Holding
630
New
56
Increased
213
Reduced
281
Closed
42
Avg Time Held
Equity + Options
1.9
years
Top 10 Avg Time Held
Equity + Options
1.8
years
Top 20 Avg Time Held
Equity + Options
2
years
Avg Time Held Equity only
1.9
years
Top 10 Avg Time Held Equity only
1.8
years
Top 20 Avg Time Held Equity only
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T. Rowe Price Blue Chip Growth ETF
TCHP
|
+$7.02M |
| 2 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$4.94M |
| 3 |
Invesco S&P SmallCap 600 Revenue ETF
RWJ
|
+$4.69M |
| 4 |
Avantis Emerging Markets Equity ETF
AVEM
|
+$4.15M |
| 5 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
|
+$17.2M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.97M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$6.66M |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$6.06M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$5.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 68.72% |
| 2 | Technology | 10.92% |
| 3 | Industrials | 4.58% |
| 4 | Healthcare | 3.57% |
| 5 | Financials | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Snap-on
SNA
$19B
| $528K | 0.04% |
1,312
-51
| -4% | -$19.3K |
2026 Q1
1 quarter
|
|
302
Stryker
SYK
$116B
| $524K | 0.03% |
1,664
-235
| -12% | -$74.1K |
2024 Q1
9 quarters
|
|
303
iShares MSCI EAFE Value ETF
EFV
$30.6B
| $522K | 0.03% |
6,819
-13
| -0.2% | -$1.01K |
2026 Q1
1 quarter
|
|
304
Danaher
DHR
$158B
| $521K | 0.03% |
2,738
-1,246
| -31% | -$226K |
2020 Q2
24 quarters
|
|
305
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.26B
| $521K | 0.03% |
9,531
+641
| +7% | +$33.6K |
2025 Q4
2 quarters
|
|
306
Prudential Financial
PRU
$39.7B
| $520K | 0.03% |
4,814
+837
| +21% | +$85.1K |
2021 Q2
20 quarters
|
|
307
Vanguard Information Technology ETF
VGT
$148B
| $518K | 0.03% |
4,331
-9,957
| -70% | -$1.09M |
2026 Q1
1 quarter
|
|
308
HCA Healthcare
HCA
$100B
| $517K | 0.03% |
1,326
+66
| +5% | +$27.9K |
2024 Q1
9 quarters
|
|
309
Clean Harbors
CLH
$16.6B
| $514K | 0.03% |
1,720
-37
| -2% | -$10.9K |
2025 Q3
3 quarters
|
|
310
Amphastar Pharmaceuticals
AMPH
$1.1B
| $513K | 0.03% |
25,405
| – | – |
2024 Q1
9 quarters
|
|
311
Ametek
AME
$56.7B
| $510K | 0.03% |
2,106
-324
| -13% | -$74.6K |
2025 Q3
3 quarters
|
|
312
T-Mobile US
TMUS
$169B
| $508K | 0.03% |
3,028
+80
| +3% | +$15.1K |
2024 Q1
9 quarters
|
|
313
Interactive Brokers
IBKR
$37.5B
| $506K | 0.03% |
5,810
-1,397
| -19% | -$116K |
2021 Q1
21 quarters
|
|
314
CRISPR Therapeutics
CRSP
$4.84B
| $504K | 0.03% |
9,249
-258
| -3% | -$13.6K |
2026 Q1
1 quarter
|
|
315
Intuitive Surgical
ISRG
$154B
| $504K | 0.03% |
1,268
-207
| -14% | -$90.4K |
2024 Q1
9 quarters
|
|
316
XPO
XPO
$21.9B
| $502K | 0.03% |
2,445
-25
| -1% | -$5.29K |
2025 Q3
3 quarters
|
|
317
iShares A.I. Innovation and Tech Active ETF
BAI
$12.9B
| $501K | 0.03% |
9,498
+1,010
| +12% | +$45.9K |
2026 Q1
1 quarter
|
|
318
Royal Caribbean
RCL
$77.5B
| $501K | 0.03% |
1,576
-43
| -3% | -$12K |
2024 Q3
7 quarters
|
|
319
Accenture
ACN
$146B
| $499K | 0.03% |
4,007
-108
| -3% | -$18.7K |
2020 Q2
24 quarters
|
|
320
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $494K | 0.03% |
6,402
-1,076
| -14% | -$79K |
2023 Q4
10 quarters
|
|
321
Invesco Semiconductors ETF
PSI
$2.6B
| $487K | 0.03% |
2,595
| – | – |
2025 Q4
2 quarters
|
|
322
Intellia Therapeutics
NTLA
$1.66B
| $485K | 0.03% |
28,688
-1,342
| -4% | -$18.8K |
2026 Q1
1 quarter
|
|
323
USCF SummerHaven Dynamic Commodity Strategy No K-1 Fund
SDCI
$832M
| $485K | 0.03% |
+18,346
| New | +$509K |
2026 Q2
0 quarters
|
|
324
iShares 0-3 Month Treasury Bond ETF
SGOV
$116B
| $482K | 0.03% |
4,788
+25
| +0.5% | +$2.51K |
2025 Q3
3 quarters
|
|
325
Northern Trust
NTRS
$30.2B
| $478K | 0.03% |
2,750
+541
| +24% | +$89.1K |
2025 Q4
2 quarters
|
|
Similar funds
NEWAS
SL
Advisor OS's Q2 2026 Portfolio in Review
As of Q2 2026, Advisor OS held 630 positions worth $1.5B, up 8.5% from $1.38B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Advisor OS's Q2 2026 filing shows 56 new, 213 increased, 281 reduced and 42 closed positions. Its largest new stake was State Street SPDR Portfolio S&P 500 High Dividend ETF: 71,384 shares worth $3.41M. The largest sale was State Street SPDR Portfolio Aggregate Bond ETF, an estimated $17.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, down from 69% a quarter earlier, followed by Technology and Industrials.
- Advisor OS's largest Q2 2026 buy was State Street SPDR Portfolio S&P 500 High Dividend ETF: 71,384 shares worth $3.41M.
- Advisor OS added most to T. Rowe Price Blue Chip Growth ETF in Q2 2026, an estimated $7.02M increase.
- Advisor OS's biggest Q2 2026 reduction was State Street SPDR Portfolio Aggregate Bond ETF, cutting an estimated $17.2M.
- Advisor OS fully exited JPMorgan BetaBuilders Japan ETF in Q2 2026, selling an estimated $2.69M.
- Advisor OS's ten largest holdings make up 37% of its $1.5B portfolio in Q2 2026.
- Advisor OS opened 56 new positions and closed 42 in Q2 2026.
- Advisor OS's portfolio value rose 8.5% quarter-over-quarter to $1.5B.
Based on Advisor OS's 13F filing for Q2 2026, filed 5 Aug 2026.